Bouran Sidibé

Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

A. Dicko, O. Doumbo, J. Ouédraogo, 2018, The Lancet.

A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.

J. Ndiaye, O. Gaye, S. Krudsood, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of Efficacy and Safety of Arterolane Maleate–Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa

J. Ndiaye, O. Gaye, B. Behera, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of the Mercy weight estimation method in Ouelessebougou, Mali

A. Dicko, S. Abdel‐Rahman, M. Traoré, 2014, BMC Public Health.

Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

A. Dicko, O. Doumbo, J. Ouédraogo, 2018, The Lancet.